Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Recruiting

Phase 2

DMAU & LNGStudy of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Sponsor:

Health Decisions

Code:

NCT03455075

Conditions

Healthy

Men

Male Contraception

Eligibility Criteria

Sex: Male

Age: 18 - 50

Healthy Volunteers: Accepted

Interventions

Dimethandrolone-Undecanoate

Levonorgestrel 0.03 MG

Placebo oral capsule

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-30. This information was provided to ClinicalTrials.gov by Health Decisions on 2019-08-12.